Medicef Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 0.10 M
as on 16-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.92 Cr
as on 16-07-2024
- Satisfied Charges ₹ 10.45 Cr
as on 16-07-2024
- Revenue %
(FY 2023)
- Profit -149556.00%
(FY 2023)
- Ebitda -36500.00%
(FY 2023)
- Net Worth -18199.58%
(FY 2023)
- Total Assets 195983.45%
(FY 2023)
About Medicef Pharma
The Corporate was formerly known as Medicef Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹25.92 Cr. The company has closed loans amounting to ₹10.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Ranka, Parveen Kumar, Dhananjay Vishwakarma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100DL2012PLC243670
- Company No.
243670
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medicef Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Ranka  | Additional Director | 13-Feb-2024 | Current |
| Parveen Kumar | Additional Director | 03-Feb-2024 | Current |
| Dhananjay Vishwakarma | Additional Director | 03-Feb-2024 | Current |
| Satyanaraian Gupta | Additional Director | 03-Feb-2024 | Current |
| Anish Rana | Additional Director | 03-Feb-2024 | Current |
Financial Performance of Medicef Pharma.
Medicef Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 149556% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18199.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicef Pharma?
In 2023, Medicef Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mediraw Pharma & Nutra Private LimitedActive 3 years 4 months
Parveen Kumar and Anish Rana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2024 | ₹14.00 Cr | Open |
Others Creation Date: 20 Sep 2023 | ₹2.00 Cr | Open |
Others Creation Date: 20 Sep 2023 | ₹5.00 M | Open |
How Many Employees Work at Medicef Pharma?
Unlock and access historical data on people associated with Medicef Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicef Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicef Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
